Role of Social and Sexual Network Factors in PrEP Utilization Among YMSM and Transgender Women in Chicago.


Journal

Prevention science : the official journal of the Society for Prevention Research
ISSN: 1573-6695
Titre abrégé: Prev Sci
Pays: United States
ID NLM: 100894724

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 4 2 2019
medline: 12 8 2020
entrez: 4 2 2019
Statut: ppublish

Résumé

Despite demonstrated efficacy, uptake of HIV pre-exposure prophylaxis (PrEP) remains low, particularly among high-risk demographics such as transgender women, Black men who have sex with men (BMSM), and young MSM (YMSM). Research thus far has largely focused on individual factors that may impede PrEP uptake in these demographics, leaving social network factors relatively unexplored. The present study used data collected from participants within RADAR, a longitudinal cohort study in Chicago focused on understanding the individual, dyadic, network, social, and biologic factors associated with HIV infection within YMSM. Of the 906 study participants who did not report an HIV diagnosis at baseline, 7.0% reported using PrEP in the prior 6 months. Recent PrEP use was associated with both individual-level (age and gender) and network-level factors (mean relationship strength, sexual network degree, etc.). These findings highlight the need to expand beyond focusing on individual-level drivers of PrEP uptake, as well as changing our understanding of who is most important within a network (centrality vs. strength of weak ties). Future work is needed to determine whether variables associated with PrEP uptake are similarly connected to PrEP adherence.

Identifiants

pubmed: 30712223
doi: 10.1007/s11121-019-00995-6
pii: 10.1007/s11121-019-00995-6
pmc: PMC6677636
mid: NIHMS1525006
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1089-1097

Subventions

Organisme : NIDA NIH HHS
ID : K08 DA037825
Pays : United States
Organisme : NIDA NIH HHS
ID : U01DA036939
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Organisme : NIDA NIH HHS
ID : K08DA037825
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA036939
Pays : United States

Références

N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
Clin Trials. 2018 Feb;15(1):44-52
pubmed: 28862483
Am J Public Health. 2012 Sep;102(9):1751-7
pubmed: 22873480
J Community Health. 2013 Oct;38(5):976-93
pubmed: 23543372
J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S54-8
pubmed: 23673888
J Behav Med. 2016 Aug;39(4):665-74
pubmed: 27001255
AIDS Behav. 2018 Nov;22(11):3637-3644
pubmed: 29728949
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
AIDS Behav. 2017 May;21(5):1376-1382
pubmed: 28238119
N Engl J Med. 2012 Aug 2;367(5):423-34
pubmed: 22784038
J Int AIDS Soc. 2017 Mar 22;20(1):21371
pubmed: 28630651
AIDS Behav. 2013 Jul;17(6):2173-9
pubmed: 23128980
AIDS Behav. 2018 Nov;22(11):3681-3691
pubmed: 29872999
Glob Public Health. 2016 Aug-Sep;11(7-8):1060-75
pubmed: 26963756
Clin Infect Dis. 2015 Nov 15;61(10):1601-3
pubmed: 26334052
Psychol Methods. 2000 Mar;5(1):44-63
pubmed: 10937322
Proc SIGCHI Conf Hum Factor Comput Syst. 2016 May;2016:5360-5371
pubmed: 28018995
Ann Epidemiol. 2017 Mar;27(3):176-180
pubmed: 28003117
AIDS Patient Care STDS. 2016 Apr;30(4):147-50
pubmed: 26982698
Virtual Mentor. 2014 Nov 01;16(11):909-15
pubmed: 25397651
AIDS Behav. 2018 Sep;22(9):3044-3056
pubmed: 29789985
PLoS One. 2015 Jun 03;10(6):e0128971
pubmed: 26039511
Lancet HIV. 2015 Dec;2(12):e502-3
pubmed: 26614960
J Clin Nurs. 2018 Sep;27(17-18):3254-3265
pubmed: 28771856
JAMA Intern Med. 2016 Jan;176(1):136-8
pubmed: 26571368
AIDS Behav. 2017 Oct;21(10):3000-3012
pubmed: 28597344
AIDS Behav. 2018 Nov;22(11):3576-3587
pubmed: 29468493
Glob Public Health. 2016 Aug-Sep;11(7-8):835-48
pubmed: 26785751
AIDS Educ Prev. 2017 Jun;29(3):205-217
pubmed: 28650227
AIDS Behav. 2017 Sep;21(9):2774-2783
pubmed: 28035497
Am J Public Health. 2010 Dec;100(12):2426-32
pubmed: 20966378
Int J STD AIDS. 2018 Mar;29(4):375-381
pubmed: 28853676
PLoS One. 2017 Sep 27;12(9):e0184014
pubmed: 28953905
AIDS. 2018 Feb 20;32(4):523-530
pubmed: 29239887
J Consult Clin Psychol. 2018 May;86(5):416-426
pubmed: 29683699
AIDS Behav. 2017 May;21(5):1288-1298
pubmed: 27401537
AIDS Patient Care STDS. 2017 Dec;31(12):517-527
pubmed: 29211513
AIDS Patient Care STDS. 2016 Jun;30(6):282-90
pubmed: 27220036
AIDS Behav. 2014 May;18(5):972-96
pubmed: 24531769
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
AIDS Educ Prev. 2015 Apr;27(2):112-25
pubmed: 25915697
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
AIDS Educ Prev. 2015 Jun;27(3):275-87
pubmed: 26010317
AIDS. 2017 Mar 13;31(5):739-740
pubmed: 28225452
Lancet HIV. 2015 Dec;2(12):e512-9
pubmed: 26614965
Curr HIV/AIDS Rep. 2014 Mar;11(1):81-92
pubmed: 24384832
Curr HIV Res. 2013 Oct;11(7):520-7
pubmed: 24476355
AIDS Behav. 2012 Apr;16(3):535-42
pubmed: 21811844

Auteurs

Gregory Phillips (G)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Glp2@northwestern.edu.

Balint Neray (B)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Michelle Birkett (M)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Dylan Felt (D)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Patrick Janulis (P)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Brian Mustanski (B)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH